SCOPUS 정보 검색 플랫폼

European Journal of Nuclear Medicine

Volumn 28, Issue 10, 2001, Pages 1552-1554

End-stage renal disease after treatment with 90Y-DOTATOC

(5) Alvarez Ayuso, L a Garcia Poblete E a Torralba, A a Fernandez H a Millan I a

a UNIVERSIDAD COMPLUTENSE DE MADRID (Spain)

Author keywords

DOTATOC; Nephrotoxicity; Renal failure; Somatostatin receptor mediated internal radiotherapy; Yttrium 90

Indexed keywords

CREATININE; FLUOROURACIL; FOLINIC ACID; HARTMANN SOLUTION; MAGNESIUM 5 SULFAT; MAGNESIUM DERIVATIVE; OCTREOTIDE[1 DEXTRO PHENYLALANINE 3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,2,7,10 TETRAACETIC ACID Y 90]; PROTEIN DERIVATIVE; PROTEINSTERIL HEPA; RINGER SOLUTION; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; UREA;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; DIURESIS; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY METASTASIS; LIVER METASTASIS; LYMPH NODE METASTASIS; NEPHROTOXICITY; PROTEINURIA; RADIATION HAZARD; RADIATION RESPONSE; SMALL INTESTINE CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

AGED; CARCINOID TUMOR; FEMALE; HUMANS; INTESTINAL NEOPLASMS; KIDNEY FAILURE, CHRONIC; OCTREOTIDE; RADIOPHARMACEUTICALS;

EID: 0034790034 PISSN: 03406997 EISSN: None Source Type: Journal
DOI: 10.1007/s002590100599 Document Type: Article

Times cited : (136)

References (12)

1
- 0030737659
- DOTATOC - A powerful new tool for receptor-mediated radionuclide therapy
- (1997) Eur J Nucl Med , vol.24 , pp. 792-795
- Otte, A.¹ Jermann, E.² Behe, M.³ Goetze, M.⁴ Bucher, H.C.⁵ Roser, H.W.⁶ Heppeler, A.⁷ Mueller-Brand, J.⁸ Maecke, H.R.⁹

2
- 0032492168
- Yttrium-90-labelled somatostatin-analogue for cancer treatment
- (1998) Lancet , vol.351 , pp. 417-418
- Otte, A.¹ Mueller-Brand, J.² Dellas, S.³ Nitzsche, E.U.⁴ Herrmann, R.⁵ Maecke, H.R.⁶

3
- 0002153069
- Peptide radiopharmaceuticals: Studies of somatostatin receptors and ligands for tumor targeting
- Shimonishi Y, ed. Dordrecht: Kluwer
- (1999) Pept Sci: Present Future, Proc Int Pept Symp, 1st. , pp. 670-673
- Froidevaux, S.¹ Heppeler, A.² Behe, M.³ Jermann, E.⁴ Otte, A.⁵ Muller-Brand, J.⁶ Macke, H.R.⁷ Hildebrand, P.⁸ Beglinger, C.⁹ Eberle, A.N.¹⁰

4
- 0032900726
- 3 octreotide (DOTATOC): A pilot study in human gliomas
- (1999) Clin Cancer Res , vol.5 , pp. 1025-1033
- Merlo, A.¹ Hausmann, O.² Wasner, M.³ Steiner, P.⁴ Otte, A.⁵ Jermann, E.⁶ Freitag, P.⁷ Reubi, J.C.⁸ Muller-Brand, J.⁹ Gratzl, O.¹⁰ Macke, H.R.¹¹

5
- 0033527006
- Yttrium-90-DOTATOC: A novel somatostatin analogue for the treatment of neuroendocrine carcinoma
- (1999) Schweiz Rundschau Med Praxis , vol.88 , pp. 1263-1268
- Otte, A.¹ Herrmann, R.² Maecke, H.R.³ Müller-Brand, J.⁴

6
- 0032725922
- Yttrium-90-DOTATOC: First clinical results
- (1999) Eur J Nucl Med , vol.26 , pp. 1439-1447
- Otte, A.¹ Herrmann, R.² Heppeler, A.³ Behe, M.⁴ Jermann, E.⁵ Powell, P.⁶ Maecke, H.R.⁷ Muller, J.⁸

7
- 0034019986
- 90Y-DOTATOC), a radiolabelled somatostatin analogue
- (2000) Clin Oncol , vol.12 , pp. 121-123
- Waldherr, C.¹ Haldemann, A.² Maecke, H.R.³ Crazzolara, A.⁴ Mueller-Brand, J.⁵

8
- 0035094321
- 3-octreotide
- DOI 10.1007/s002590100490
- (2001) Eur J Nucl Med , vol.28
- Paganelli, G.¹ Zoboli, S.² Cremonesi, M.³ Bodei, L.⁴ Ferrari, M.⁵ Grana, C.⁶ Bartolomei, M.⁷ Orsi, F.⁸ De Cicco, C.⁹ M̈cke, H.R.¹⁰ Chinol, M.¹¹ De Braud, F.¹²

9
- 0031459449
- Overcoming the nephrotoxicity of radiometal labelled immunoconjugates
- (1997) Cancer , vol.80
- Behr, T.M.¹ Sharkey, R.M.² Sgouros, G.³

10
- 0023004811
- Radiation nephritis. Clinical manifestations and pathophysiologic mechanisms
- (1986) Urology , vol.27 , pp. 389-393
- Krochak, R.J.¹ Baker, D.G.²

11
- 0031944621
- Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy
- (1998) Int J Radiat Biol , vol.73 , pp. 415-421
- Moulder, J.E.¹ Fish, B.L.² Cohen, E.P.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.